cj healthcare

Korean pharma deal shows value of R&D and brands

Kolmar Korea goes up the value chain with the acquisition of CJ Healthcare to keep one step ahead of potential digital disruption in the sector.

February 21, 2018

Korean biopharma looks for the perfect IPO formula

Expect a slew of biopharmaceutical IPOs from Korea, as companies capitalise on Seoul’s ambition to develop a biotechnology hub. That's if politics doesn't get in the way.

March 13, 2017